Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Minneapolis-St. Paul-Bloomington, MN-WI MSA — October 2026
Twin Cities job growth stalls while life sciences pay accelerates
Minneapolis-St. Paul employment has fallen for three straight months, yet Clinical Research Associate pay climbed to $110,000 — 22% above the national median — as specialized talent stays scarce.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Metro employment change: -0.2% — September MoM; no growth since June (DEED)
- Metro unemployment rate: 4.4% — vs 4.1% national rate (June 2026)
- CRA pay premium, metro vs national: +22% — $110,000 metro vs $90,065 national median
- National lab/R&D vacancy rate: 23.2% — Top 13 U.S. life sciences markets, Q1 2026
Key takeaways
Metro manufacturing strength is a life sciences signal.
Durable goods manufacturing added nearly 6,800 jobs locally even as Finance and Professional Services contracted, consistent with sustained biologics and device production investment nationally. Validation Engineer pay held flat at $99,682, suggesting the hiring is real but has not yet tipped into acute wage pressure for this role.
Clinical Research Associate pay is pulling away from the national baseline.
Metro CRA pay advertised at $110,000 against a national median of $90,065 — a gap of roughly 22% — mirrors national reporting that experienced CRAs are the bottleneck constraining clinical trial capacity. Expect this premium to persist as long as the 1.9% national quit rate keeps incumbent CRAs from moving.
Regulatory Affairs pay is diverging locally from the national trend.
Metro Regulatory Affairs Specialist pay rose moderately to $117,000 while the national median fell to $103,780, a spread that suggests Twin Cities employers are competing harder for compliance expertise than the broader market. Organizations benchmarking against national survey data risk underpricing this role for local retention.
Lab Technician pay softness looks like a local anomaly worth testing.
Metro Lab Technician pay slipped to $47,840, matching the flat national figure after a local decline, even as lab/R&D vacancy nationally runs above 23%. Worth confirming whether this reflects an actual easing in entry-level lab supply or a temporary dip in advertised postings.
Median advertised pay by role — Minneapolis-St. Paul-Bloomington, MN-WI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $129,218 | $145,000 | $160,263 | Moderate increase | $130,339 |
| Clinical Research Associate | $68,644 | $110,000 | $130,222 | Significant increase | $90,065 |
| Lab Technician | $41,693 | $47,840 | $52,287 | Moderate decline | $47,840 |
| Regulatory Affairs Specialist | $91,624 | $117,000 | $125,885 | Moderate increase | $103,780 |
| Clinical Data Manager | $90,999 | $95,124 | $107,222 | Stable | $123,653 |
| Biostatistician | $105,066 | $145,000 | $148,000 | Significant increase | $131,958 |
| Validation Engineer | $86,023 | $99,682 | $107,433 | Stable | $106,478 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Minneapolis-St. Paul-Bloomington has not posted positive monthly job growth since June, and September's 0.2% employment decline arrived alongside a metro unemployment rate running roughly a half-point above year-ago levels, even as high-wage sectors like Finance and Professional/Business Services contract. Life sciences remains a counterweight to that softness: Manufacturing posted the metro's largest real job gain (+7,861 jobs, +4% year-over-year), driven by durable goods production, as Abbott and Bio-Techne anchor a region where lab and R&D vacancy nationally sits above 23%.
What it means
Metro-wide softness is masking a bifurcated talent market: general labor supply is loosening while regulatory affairs, clinical operations, and biomanufacturing talent stay scarce enough to command advertised pay gains of 4-10% locally even as national Regulatory Affairs pay has slipped. That divergence sharpens build-vs-outsource math — CRO and CDMO capacity may look more attractive where permanent clinical or manufacturing headcount is hard to fill at current offers, while softer corporate-function markets create rare near-term leverage for recruiting operations and finance support roles into life sciences. Consider reviewing which R&D and quality roles have sat open longest before assuming broader metro labor softening will ease those specific searches.
Looking ahead
Early indicator: Watch whether Minnesota's rising WARN activity in manufacturing and healthcare — paired with 3M's October filing — pushes experienced quality and operations talent into the life sciences candidate pool, which could ease some manufacturing hiring pressure.
Expected: EUDAMED's May 2026 rollout and EU AI Act implementation are driving premium pay for regulatory and compliance talent globally; device and diagnostics employers with EU-market exposure should expect continued upward pressure on Regulatory Affairs offers locally.
Worth watching: Minnesota's unemployment rate (4.5%) has now exceeded the national rate every month this year, an unusual pattern state economists are still unpacking — monitor whether this reflects an actual labor force contraction or measurement effects before adjusting metro pay strategy broadly.
Potential inflection point: National quit rates remain pinned at 1.9% despite 64% of biopharma organizations actively recruiting, meaning most 2026 headcount growth will have to come from outside hires, with internal mobility contributing little. Expect continued pressure on advertised pay for CRA and CMC roles where supply is tightest.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.